Company Search:
Advanced Search
Sponsored Links
XTL BIopharmaceuticals Limited Company Snapshot
XTL BIopharmaceuticals Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares XTL BIopharmaceuticals Limited with three other pharmaceutical manufacturers in Middle East: Rosetta Genomics Ltd. (USA) (2013 sales of 1.46 million Israel Shekels [US$421,727.50 ] ), Philadelphia Pharmaceuticals Industry Company PSC of Jordan (4.49 million Jordanian Dinars [US$6.34 million] ), and Sabaa International Co For Pharmaceutical And Chemical Industries which is based in Egypt (15.32 million Egyptian Pounds [US$871,467.63 ] ).

Sales Analysis.
  Stock Performance Chart for XTL BIopharmaceuticals Limited
  Stock Data: Recent Stock Performance:
  Current Price (3/15/2018): .06
(Figures in Israel Shekels)
1 Week -5.0%   13 Weeks -17.4%  
4 Weeks -32.9%   52 Weeks -38.7%  
XTL BIopharmaceuticals Limited Key Data:
  Ticker: XTLB Country: Israel
  Exchanges: OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2013 Sales 8,530,485
(Year Ending Jan 2014).
Employees: 6
  Currency: Israel Shekels Market Cap: 29,309,731
  Fiscal Yr Ends: December Shares Outstanding: 514,205,799
  Share Type: Ordinary Closely Held Shares: 108,836,403
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.